Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma

NCT05994235 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma

Interventions

DRUG: Mosunetuzumab
DRUG: Tazemetostat Pill

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]
[object Object]